Correction to: Cost Effectiveness of Endovascular Ultrasound Renal Denervation in Patients with Resistant Hypertension (PharmacoEconomics - Open, (2024), 10.1007/s41669-024-00472-z)

Taylor RS, Bentley A, Metcalfe K, Lobo MD, Kirtane AJ, Azizi M, Clark C, Murphy K, Boer JH, van Keep M, Ta AT, Barman NC, Schwab G, Akehurst R, Schmieder R (2024)

Publication Type: Journal article, Erratum

Publication year: 2024

Journal

PharmacoEconomics - Open Springer

DOI: 10.1007/s41669-024-00485-8

Abstract

In this article, the columns of Tables 2 and 3 have been incorrectly labelled: 'uRDN' and 'uRDN plus SoC'. They should read: ‘uRDN plus SoC’ and 'SoC alone’. The original article has been corrected.

Authors with CRIS profile

Roland Schmieder Professur für Innere Medizin (Nephrologie)

Involved external institutions

University of Glasgow GB United Kingdom (GB) Mtech Access Limited GB United Kingdom (GB) Queen Mary, University of London GB United Kingdom (GB) Columbia University Irving Medical Center (CUIMC) US United States (USA) (US) University of Exeter GB United Kingdom (GB) ReCor Medical Inc. US United States (USA) (US) Université Paris-Sud FR France (FR)

How to cite

APA:

Taylor, R.S., Bentley, A., Metcalfe, K., Lobo, M.D., Kirtane, A.J., Azizi, M.,... Schmieder, R. (2024). Correction to: Cost Effectiveness of Endovascular Ultrasound Renal Denervation in Patients with Resistant Hypertension (PharmacoEconomics - Open, (2024), 10.1007/s41669-024-00472-z). PharmacoEconomics - Open. https://doi.org/10.1007/s41669-024-00485-8

MLA:

Taylor, Rod S., et al. "Correction to: Cost Effectiveness of Endovascular Ultrasound Renal Denervation in Patients with Resistant Hypertension (PharmacoEconomics - Open, (2024), 10.1007/s41669-024-00472-z)." PharmacoEconomics - Open (2024).

BibTeX: Download